Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study

• Sanne M.H. Zweijpfenning,
• Stephan E.P. Kops,
• Martin J. Boeree,
• Saskia Kuipers,
• Jakko van Ingen,
• Wouter Hoefsloot,
• Cecile Magis-Escurra

Affiliations

Sanne M.H. Zweijpfenning

Dept of Respiratory Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands

Stephan E.P. Kops

Dept of Respiratory Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands

Martin J. Boeree

Dept of Respiratory Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands

Saskia Kuipers

Dept of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands

Jakko van Ingen

Dept of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands

Wouter Hoefsloot

Dept of Respiratory Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands

Cecile Magis-Escurra

Dept of Respiratory Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands